Remove Gene Sequencing Remove Genome Remove Licensing
article thumbnail

Boost for mRNA as Moderna to acquire OriCiro for $85 million

pharmaphorum

and OriCiro Genomics K.K. Nonetheless, Moderna has previously been involved in licensing deals to advance its technology. The data was from their phase 2b trial of a personalised vaccine consisting of 34 mRNAs, each targeting mutations – identified by gene sequencing – thought to be driving a patient’s cancer.

article thumbnail

Oxford Nanopore makes stellar debut on UK stock market

pharmaphorum

It may also use the cash injection for “in-licensing opportunities and potential acquisitions”, according to the document. Chief technology officer Clive Brown is also sitting on a £10 million stake. The post Oxford Nanopore makes stellar debut on UK stock market appeared first on.

article thumbnail

A Reversal on Sequencing? Proposed Legislation Would Allow Patenting of Naturally Occurring Genes

FDA Law Blog

Rather, developers of diagnostic tests and, indeed of any product that relies on free access to gene sequence and other biomarker information, should pay also close attention, as PERA would overturn longstanding judicial precedent. By 2010, about 2000 isolated human genes had been patented in the U.S.

Gene 64